VINCI S.A. INH. EO 2,50/ FR0000125486 /
30/05/2024 8:07:08 | Diferencia -0.9500 | Volumen | Bid8:51:23 | Ask8:51:23 | Capitalización de mecado | Dividendo A. | P/E Ratio |
---|---|---|---|---|---|---|---|
112.6000EUR | -0.84% | 0 Volumen de negocios: 0.0000 |
112.6500Volumen de oferta: 68 | 112.9000Tamaño/ Volumen/ Formato de Ask: 68 | 66.65 mil millonesEUR | 3.98% | 13.67 |
GlobeNewswire
9:01
Persistent Systems Selects Zscaler to Launch Technology Modernization and Renewable Energy Initiativ...
GlobeNewswire
9:00
Curium Announces First Commercial Doses in France of Pylclari® – an Innovative 18F-Psma Pet Tracer I...
GlobeNewswire
9:00
Green Bioactives Reports Remarkable Cognitive Benefits of its Newly Launched Memory-boosting Nutrace...
GlobeNewswire
8:35
Nxera Pharma to Receive $4.6 Million in Milestone Payments from Centessa Pharmaceuticals
GlobeNewswire
8:30
Samsung Bioepis to Present Post-hoc Analysis of Phase 3 Study for EPYSQLI™ (SB12; Eculizumab Biosimi...
GlobeNewswire
8:30
BlueRock Therapeutics receives FDA Regenerative Medicine Advanced Therapy designation for Parkinson’...
GlobeNewswire
8:30
Nxera Pharma and PrecisionLife Expand Strategic R&D Partnership into New Therapeutic Area
GlobeNewswire
8:30
Combined General Meeting of June 20, 2024 - Availability of the preparatory documents
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página